Letters by company

DiaMedica Therapeutics Inc.

1 letter discussing DMAC. Everything written about it on this site is on its ticker page.

1 Main Capital Q2 2026 - Letter 1 Main Capital initiated Hilton Grand Vacations, arguing its recurring management fees, financing spread and aggressive repurchases are mispriced by investors’ views of timeshare cyclicality. The fund also outlines an opportunistic DiaMedica Therapeutics stake, citing DM199’s stroke and preeclampsia programs, clinical catalysts and a planned strategic sale path. second quarter DMAC $422MHGV $2.8B